Clinical Trial

Structured Follow-up Intervention on Glucose Status After Pancreatic Cancer Surgery

Study acronym: FiGluR
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated January 23, 2025 (before its estimated November 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The primary aim of the present study is to examine the effect of a "structured follow-up intervention" to be performed in the first three months after PD on blood glucose. The exploratory aim of the study is to examine the effect of the "structured follow-up intervention" to be performed in the first three months after PD on patient outcomes (mortality, rehospitalization and having surgery, wound site complications, bile leakage, delayed gastric emptying, pancreatic fistula, myocardial infarct, cardiac arythmia, pneumonia, intraabdominal abscess, bleeding and pain) and the quality of life. The secondary aim of the study is to evaluate the factors affecting glucose levels in three months after PD by using data mining. Data mining will allow evaluation of all the factors affecting glucose levels by using detailed blood glucose predictors obtained through continuous glucose monitoring after PD. The study has a single-center, randomized, controlled, single-blind design. The study sample will include 40 patients with PD. The allocation ratio will be 1:1. Since being diagnosed as diabetes before surgery is an important variable, block randomization will be performed depending on whether the patients have the diagnosis of diabetes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-13.
Trial Details
NCT Number NCT06774170
Lead Sponsor Dokuz Eylul University
Collaborators: The Scientific and Technological Research Council of Turkey
Conditions Pancreas Cancer, Diabetes
Enrollment 40 participants
Start Date 2024-04-01
Primary Completion 2025-11-01 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-01-23